Rigel Pharmaceuticals Inc (RIGL)
EBITDA Margin
32.03%
Quarterly · Period ending:
RIGL EBITDA Margin
Latest reported32.03%period ending
Latest reported32.03%period ending
RIGL Quarterly EBITDA Margin (100.00% → 32.03%)
Quarterly ebitda margin
High-resolution chart · PNG
RIGL ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 32.0344% | |
| 23.2701% | |
| 35.8356% | |
| 43.3575% | |
| 61.4279% | |
| 26.1902% | |
| 30.8719% | |
| 27.2877% | |
| 4.3756% | |
| -20.2241% | |
| 8.2057% | |
| -12.444% | |
| -16.5216% | |
| -45.934% | |
| 5.4448% | |
| -80.1919% | |
| -42.5433% | |
| -155.3809% | |
| -102.886% | |
| -90.5631% | |
| -48.6332% | |
| 51.8342% | |
| -100.8238% | |
| -73.8485% | |
| -106.479% | |
| 38.6578% | |
| -108.3961% | |
| -54.2552% | |
| -196.339% | |
| -138.102% | |
| 7.1189% | |
| -485.2415% | |
| -1,452.2664% | |
| 0% | |
| 0% | |
| -1,971.4444% | |
| 0% | |
| -448.5491% | |
| -521.4667% | |
| -445.6117% | |
| -155.7831% | |
| -342.8713% | |
| -145.3555% | |
| -49.9692% | |
| -262.2492% | |
| -817.539% | |
| -264.9818% | |
| 0% | |
| 0% | |
| 0% | |
| -304.8696% | |
| 0% | |
| -1,589.7857% | |
| 0% | |
| 0% | |
| 0% | |
| -1,618.1333% | |
| -3,034.4% | |
| 0% | |
| -402.6406% | |
| -5,336.962% | |
| 0% | |
| 13.46% | |
| 70.2457% | |
| 55.1388% | |
| -676.0196% | |
| -3,294.6667% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -249.025% | |
| 0% | |
| -1,036.1963% | |
| -677.0802% | |
| -526.3747% | |
| -202.4155% | |
| -22.8964% | |
| -95.8169% | |
| -159.5681% | |
| -416.3315% | |
| -268.2154% | |
| -424.6753% | |
| -1,289.4545% | |
| -2,401.6692% | |
| -806.3215% | |
| -840.1479% | |
| -532.7635% | |
| -492.059% | |
| -406.0451% | |
| -145.5192% | |
| -178.7027% | |
| -241.9929% | |
| -208.0932% | |
| -163.8604% | |
| -93.5551% | |
| -113.6947% |